These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6282661)

  • 1. [Suppressibility of parathyroid function in primary hyperparathyroidism as estimated by nephrogenous cyclic AMP (author's transl)].
    Sohn HE; Yumita S; Unakami H; Miura R; Furukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):110-21. PubMed ID: 6282661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenous cyclic AMP as a parathyroid function test.
    Broadus AE
    Nephron; 1979; 23(2-3):136-41. PubMed ID: 220548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T; Hirano Y; Ueda D; Niijima T
    Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J; Holmegaard SN; Siggaard-Andersen O
    Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical changes before and during oral calcium tolerance test in calcium stone formers.
    Kitamura T; Hirano Y; Ueda D; Aso Y
    Urol Res; 1988; 16(3):149-55. PubMed ID: 2842910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism].
    Bill G; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal calcium metabolism in myotonic dystrophy (II): Increased level of nephrogenous cyclic AMP and serum immunoreactive parathyroid hormone].
    Yoshida H; Kinoshita M; Oshima H; Saito E
    Nihon Naibunpi Gakkai Zasshi; 1988 Jul; 64(7):539-46. PubMed ID: 2851465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
    Naafs MA; Hackeng WH; Koorevaar G; Silberbusch J
    Bone Miner; 1988 Jul; 4(3):289-98. PubMed ID: 2847840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
    Dumoulin G; Hory B; Nguyen NU; Henriet MT; Bresson C; Regnard J; Saint-Hillier Y
    Am J Nephrol; 1995; 15(3):238-44. PubMed ID: 7618649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
    Insogna KL; Mitnick ME; Stewart AF; Burtis WJ; Mallette LE; Broadus AE
    N Engl J Med; 1985 Oct; 313(18):1126-30. PubMed ID: 2995810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenous adenosine 3'5' monophosphate as an index of parathyroid function in chronic renal disease.
    Czekalski S; Baczyk K
    Proc Eur Dial Transplant Assoc; 1977; 14():451-60. PubMed ID: 202946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J; Heath H
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in nephrogenous cyclic AMP excretion and plasma cyclic AMP following treatment of hyperthyroidism.
    Naafs MA; van der Velden PC; Fischer HR; Koorevaar G; van Duin S; Hackeng WH; Schopman W; Silberbusch J
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):477-81. PubMed ID: 6206676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
    Rude RK; Oldham SB; Singer FR
    Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC; Kukreja SC; Lad TE; Shemerdiak WP; York PA
    Horm Metab Res; 1984 Apr; 16(4):204-7. PubMed ID: 6327481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.
    Suzuki K; Nonaka K; Kono N; Ichihara K; Fukumoto Y; Inui Y; Miyagawa J; Onishi T; Hayashi C; Tarui S
    Calcif Tissue Int; 1986 Nov; 39(5):304-9. PubMed ID: 3028586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.
    Goldsmith RS; Furszyfer J; Johnson WJ; Fournier AE; Sizemore GW; Arnaud CD
    J Clin Invest; 1973 Jan; 52(1):173-80. PubMed ID: 4734166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.